BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 31530281)

  • 1. Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signaling.
    Nath D; Li X; Mondragon C; Post D; Chen M; White JR; Hryniewicz-Jankowska A; Caza T; Kuznetsov VA; Hehnly H; Jamaspishvili T; Berman DM; Zhang F; Kung SHY; Fazli L; Gleave ME; Bratslavsky G; Pandolfi PP; Kotula L
    Cell Commun Signal; 2019 Sep; 17(1):120. PubMed ID: 31530281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel non-canonical Wnt signature for prostate cancer aggressiveness.
    Sandsmark E; Hansen AF; Selnæs KM; Bertilsson H; Bofin AM; Wright AJ; Viset T; Richardsen E; Drabløs F; Bathen TF; Tessem MB; Rye MB
    Oncotarget; 2017 Feb; 8(6):9572-9586. PubMed ID: 28030815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical implication of Frizzled 2 expression and its association with epithelial-to-mesenchymal transition in hepatocellular carcinoma.
    Asano T; Yamada S; Fuchs BC; Takami H; Hayashi M; Sugimoto H; Fujii T; Tanabe KK; Kodera Y
    Int J Oncol; 2017 May; 50(5):1647-1654. PubMed ID: 28350091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metastasis suppressor CD82/KAI1 represses the TGF-β
    Lee MS; Lee J; Kim YM; Lee H
    Prostate; 2019 Sep; 79(12):1400-1411. PubMed ID: 31212375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Wnt/beta-catenin signaling pathway in epithelial-mesenchymal transition of human prostate cancer induced by hypoxia-inducible factor-1alpha.
    Jiang YG; Luo Y; He DL; Li X; Zhang LL; Peng T; Li MC; Lin YH
    Int J Urol; 2007 Nov; 14(11):1034-9. PubMed ID: 17956532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing effects of FOXD1 inhibit metastatic potentials of the PCa via N-cadherin - Wnt/β-catenin crosstalk.
    Donmez C; Konac E
    Gene; 2022 Aug; 836():146680. PubMed ID: 35738443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promotion of epithelial-mesenchymal transition by Frizzled2 is involved in the metastasis of endometrial cancer.
    Bian Y; Chang X; Liao Y; Wang J; Li Y; Wang K; Wan X
    Oncol Rep; 2016 Aug; 36(2):803-10. PubMed ID: 27373314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis.
    Gujral TS; Chan M; Peshkin L; Sorger PK; Kirschner MW; MacBeath G
    Cell; 2014 Nov; 159(4):844-56. PubMed ID: 25417160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PMA treated THP-1-derived-IL-6 promotes EMT of SW48 through STAT3/ERK-dependent activation of Wnt/β-catenin signaling pathway.
    Gao S; Hu J; Wu X; Liang Z
    Biomed Pharmacother; 2018 Dec; 108():618-624. PubMed ID: 30243096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
    Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
    Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt3a expression is associated with epithelial-mesenchymal transition and promotes colon cancer progression.
    Qi L; Sun B; Liu Z; Cheng R; Li Y; Zhao X
    J Exp Clin Cancer Res; 2014 Dec; 33(1):107. PubMed ID: 25499541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases.
    Baruah MM; Khandwekar AP; Sharma N
    Tumour Biol; 2016 Oct; 37(10):14025-14034. PubMed ID: 27495232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
    Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
    Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIRT3 inhibits prostate cancer metastasis through regulation of FOXO3A by suppressing Wnt/β-catenin pathway.
    Li R; Quan Y; Xia W
    Exp Cell Res; 2018 Mar; 364(2):143-151. PubMed ID: 29421536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells.
    Liu H; Yin J; Wang H; Jiang G; Deng M; Zhang G; Bu X; Cai S; Du J; He Z
    Cell Signal; 2015 Mar; 27(3):510-8. PubMed ID: 25578861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
    Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
    Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The peptide mimicking small extracellular ring domain of CD82 inhibits epithelial-mesenchymal transition by downregulating Wnt pathway and upregulating hippo pathway.
    He X; Huang X; Wang C; Luan M; Li Y; Ma X; Ma K
    Biochem Biophys Res Commun; 2020 Dec; 533(3):338-345. PubMed ID: 32958256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells.
    Gupta S; Iljin K; Sara H; Mpindi JP; Mirtti T; Vainio P; Rantala J; Alanen K; Nees M; Kallioniemi O
    Cancer Res; 2010 Sep; 70(17):6735-45. PubMed ID: 20713528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FERMT1 mediates epithelial-mesenchymal transition to promote colon cancer metastasis via modulation of β-catenin transcriptional activity.
    Liu CC; Cai DL; Sun F; Wu ZH; Yue B; Zhao SL; Wu XS; Zhang M; Zhu XW; Peng ZH; Yan DW
    Oncogene; 2017 Mar; 36(13):1779-1792. PubMed ID: 27641329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erbin Suppresses KSR1-Mediated RAS/RAF Signaling and Tumorigenesis in Colorectal Cancer.
    Stevens PD; Wen YA; Xiong X; Zaytseva YY; Li AT; Wang C; Stevens AT; Farmer TN; Gan T; Weiss HL; Inagaki M; Marchetto S; Borg JP; Gao T
    Cancer Res; 2018 Sep; 78(17):4839-4852. PubMed ID: 29980571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.